A detailed history of Xponance, Inc. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Xponance, Inc. holds 20,650 shares of ALNY stock, worth $4.87 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
20,650
Previous 21,076 2.02%
Holding current value
$4.87 Million
Previous $5.12 Million 10.92%
% of portfolio
0.06%
Previous 0.05%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$233.81 - $287.01 $99,603 - $122,266
-426 Reduced 2.02%
20,650 $5.68 Million
Q2 2024

Aug 14, 2024

BUY
$143.31 - $247.0 $197,481 - $340,366
1,378 Added 7.0%
21,076 $5.12 Million
Q1 2024

May 13, 2024

BUY
$146.51 - $198.2 $821,774 - $1.11 Million
5,609 Added 39.81%
19,698 $2.94 Million
Q4 2023

Jan 31, 2024

SELL
$151.41 - $196.57 $135,511 - $175,930
-895 Reduced 5.97%
14,089 $2.7 Million
Q3 2023

Oct 23, 2023

BUY
$170.77 - $211.65 $18,613 - $23,069
109 Added 0.73%
14,984 $2.65 Million
Q2 2023

Jul 13, 2023

SELL
$185.01 - $212.05 $363,174 - $416,254
-1,963 Reduced 11.66%
14,875 $2.83 Million
Q1 2023

Apr 17, 2023

BUY
$182.66 - $235.53 $29,408 - $37,920
161 Added 0.97%
16,838 $3.37 Million
Q4 2022

Jan 23, 2023

BUY
$185.53 - $241.31 $436,366 - $567,561
2,352 Added 16.42%
16,677 $0
Q3 2022

Oct 24, 2022

BUY
$138.54 - $232.0 $3,047 - $5,104
22 Added 0.15%
14,325 $2.87 Million
Q2 2022

Aug 02, 2022

BUY
$120.42 - $169.29 $62,618 - $88,030
520 Added 3.77%
14,303 $2.09 Million
Q1 2022

Apr 20, 2022

BUY
$127.18 - $173.91 $49,218 - $67,303
387 Added 2.89%
13,783 $2.25 Million
Q4 2021

Jan 31, 2022

BUY
$159.56 - $209.29 $1,436 - $1,883
9 Added 0.07%
13,396 $2.27 Million
Q3 2021

Nov 05, 2021

SELL
$169.75 - $207.73 $55,338 - $67,719
-326 Reduced 2.38%
13,387 $2.53 Million
Q2 2021

Aug 12, 2021

BUY
$128.63 - $176.89 $213,268 - $293,283
1,658 Added 13.75%
13,713 $2.33 Million
Q1 2021

May 10, 2021

SELL
$126.83 - $175.69 $3,043 - $4,216
-24 Reduced 0.2%
12,055 $1.7 Million
Q4 2020

Feb 11, 2021

BUY
$122.97 - $147.0 $14,018 - $16,758
114 Added 0.95%
12,079 $1.57 Million
Q3 2020

Oct 26, 2020

BUY
$121.19 - $165.49 $16,603 - $22,672
137 Added 1.16%
11,965 $1.74 Million
Q2 2020

Aug 14, 2020

BUY
$104.21 - $156.44 $1.23 Million - $1.85 Million
11,828 New
11,828 $1.75 Million

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $29B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Xponance, Inc. Portfolio

Follow Xponance, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.